$3.750
+0.051 (+1.35%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
SABS 相似圖表分析預測
Alphio's SABS stock price prediction model matches the current SAB Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.73 (-0.54%). The 1-week path is $3.71 (-1.01%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 SAB Biotherapeutics Inc 股票嗎？
SAB Biotherapeutics Inc is a good buy right now due to its current price of $3.79, which is significantly lower than the average analyst price target of $12.75, suggesting a potential upside of over 235%. Additionally, the company has a strong cash position of $217.6 million, providing operational runway through 2028 despite recent losses. However, the main risk is the net loss of $22.49 million reported in Q2 2026, which highlights ongoing financial challenges.
SABS 股價於 Wednesday 收在 $3.75，此前上漲 +1.35%
SAB Biotherapeutics Inc (SABS) last closed at $3.75, gaining +1.35%. These facts feed the 1-day and 1-week SABS price prediction above.
預測驅動因素
SAB Biotherapeutics Inc（SABS）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似圖表形態
近期走勢與 SABS 最接近的股票，依相似度排序。
SABS 季節性分析
Historically the probability of a positive September return for SABS is 0.00%. December offers the highest probability of a positive month at 37.21%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。